Medicare Durable Equipment Cuts Will Deepen In Next Round Of Competitive Bidding
This article was originally published in The Gray Sheet
Executive Summary
Starting July 1, Medicare plans to pay 45 percent less than current fee-schedule rates for eight categories of DMEPOS in 91 cities, and 72 percent less nationwide for diabetes products.
You may also be interested in...
Medicare Competitive Bidding Makes Big Impression On U.S. Diabetes Device Earnings
Johnson & Johnson and Abbott Laboratories each reported massive double-digit revenue drops for their U.S. diabetes product divisions in earnings reports this week, citing the impact of the national Medicare competitive bidding program for diabetes supplies. Roche had better-looking results for the most recent quarter, but also has taken a big hit from massive reimbursement cuts resulting from nationwide bidding.
Medicare Competitive Bidding Makes Big Impression On U.S. Diabetes Device Earnings
Johnson & Johnson and Abbott Laboratories each reported massive double-digit revenue drops for their U.S. diabetes product divisions in earnings reports this week, citing the impact of the national Medicare competitive bidding program for diabetes supplies. Roche had better-looking results for the most recent quarter, but also has taken a big hit from massive reimbursement cuts resulting from nationwide bidding.
DME Suppliers Down 27 Percent In Competitive Bidding Areas In 2012 – GAO
Durable medical equipment suppliers dropped by 27 percent in Medicare competitive bidding areas while only 5 percent of DME suppliers were lost in comparable, non-bidding areas. But the second year of the program’s round 1 rebid in 2012 saved Medicare $400 million, according to a newly-released Government Accountability Office report.